newsfilter
← Latest News
GlobeNewswire·

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results

Positive momentum continues for U.S. launch of FINTEPLA® (fenfluramine) oral solution in Dravet syndrome, with total net product sales of $8.1 million in the fourth quarter; total net sales of $9.6...